Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Octane Orthobiologics To Launch New Line Of Orthopedic Implants, Wins Grant From Queen’s Park

Octane Orthobiologics Inc. (Octane Orthobiologics), a division of Octane Medical Group, will receive grant from Queen's Park, according to the Kingston Whig-Standard. The grant, from Queen's Park, will use to open six new, full-time technical and manufacturing set-up positions in Kingston. The job additions will help the local manufacturer of bioactive medical products to launch a new line of orthopedic implants

Octane Orthobiologics will increase its work force of 11 by about 50%. The company will recruit work force locally but also hopes to attract specialists from elsewhere into the area.

Octane Orthobiologics Inc. chief executive officer Dr. Timothy Smith said, adding the jobs will help the local manufacturer of bioactive medical products launch a new line of orthopedic implants.

We will be expanding our technical team to develop and finalize and launch these products, he said.

Since its incorporation in 2007, Octane has been involved in the research and development of new spinal implants for people with degenerative disc disease.

Conventional orthopedic products are generally made with plastic but Octane makes its implants with a biomineral that has similar components to a natural bone, Smith said.

Octane applied for provincial funding under the government’s Eastern Ontario Development Fund.

Octane Orthobiologics designs, develops and manufactures innovative medical implants using advanced biomaterials.